Clinical trial
Toremifene in Treating Patients With Ovarian Cancer
NCT00003865 · George Washington University, Other · Withdrawn
Key facts
| NCT number | NCT00003865 |
|---|---|
| Title | Toremifene in Treating Patients With Ovarian Cancer |
| Official title | Phase II Study of Two Dose Levels of Toremifene in the Treatment of Chemotherapy-Resistant Papillary Carcinoma of the Ovary |
| Lead sponsor | George Washington University, Other |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Ovarian Cancer |
| Intervention type | Drug |
| Interventions | toremifene |
| Enrollment | 0 |
| Start date | Jul 22, 1999 |
| Primary completion | Feb 22, 2017 |
| Completion | Feb 22, 2017 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 13, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: